Global Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Vaccines market size was valued at US$ 49420 million in 2024 and is forecast to a readjusted size of USD 71450 million by 2031 with a CAGR of 5.5% during review period.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
This report is a detailed and comprehensive analysis for global Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vaccines market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccines, with price, sales quantity, revenue, and global market share of Vaccines from 2020 to 2025.
Chapter 3, the Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccines.
Chapter 14 and 15, to describe Vaccines sales channel, distributors, customers, research findings and conclusion.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
This report is a detailed and comprehensive analysis for global Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vaccines market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccines, with price, sales quantity, revenue, and global market share of Vaccines from 2020 to 2025.
Chapter 3, the Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccines.
Chapter 14 and 15, to describe Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Recombinant Vaccines
1.3.3 Viral Vaccines
1.3.4 Polysaccharide Vaccines
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Vaccines Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Rabies vaccine
1.4.3 Influenza vaccine
1.4.4 HPV vaccine
1.4.5 Hepatitis B
1.4.6 Hepatitis A
1.4.7 Leprosy vaccine
1.4.8 Polio vaccine
1.4.9 JE vaccine
1.4.10 Others
1.5 Global Vaccines Market Size & Forecast
1.5.1 Global Vaccines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Vaccines Sales Quantity (2020-2031)
1.5.3 Global Vaccines Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Vaccines Product and Services
2.1.4 GSK Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Vaccines Product and Services
2.2.4 Sanofi Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Sanofi Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Vaccines Product and Services
2.3.4 Merck Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Vaccines Product and Services
2.4.4 Pfizer Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Pfizer Recent Developments/Updates
2.5 Novartis(GSK)
2.5.1 Novartis(GSK) Details
2.5.2 Novartis(GSK) Major Business
2.5.3 Novartis(GSK) Vaccines Product and Services
2.5.4 Novartis(GSK) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis(GSK) Recent Developments/Updates
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Vaccines Product and Services
2.6.4 CSL Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 CSL Recent Developments/Updates
2.7 MedImmune LLC
2.7.1 MedImmune LLC Details
2.7.2 MedImmune LLC Major Business
2.7.3 MedImmune LLC Vaccines Product and Services
2.7.4 MedImmune LLC Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 MedImmune LLC Recent Developments/Updates
2.8 J&J(Crucell)
2.8.1 J&J(Crucell) Details
2.8.2 J&J(Crucell) Major Business
2.8.3 J&J(Crucell) Vaccines Product and Services
2.8.4 J&J(Crucell) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 J&J(Crucell) Recent Developments/Updates
2.9 China National Biotec
2.9.1 China National Biotec Details
2.9.2 China National Biotec Major Business
2.9.3 China National Biotec Vaccines Product and Services
2.9.4 China National Biotec Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 China National Biotec Recent Developments/Updates
2.10 Tiantan
2.10.1 Tiantan Details
2.10.2 Tiantan Major Business
2.10.3 Tiantan Vaccines Product and Services
2.10.4 Tiantan Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Tiantan Recent Developments/Updates
2.11 Hualan
2.11.1 Hualan Details
2.11.2 Hualan Major Business
2.11.3 Hualan Vaccines Product and Services
2.11.4 Hualan Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Recent Developments/Updates
2.12 Kangtai
2.12.1 Kangtai Details
2.12.2 Kangtai Major Business
2.12.3 Kangtai Vaccines Product and Services
2.12.4 Kangtai Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Kangtai Recent Developments/Updates
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Vaccines Product and Services
2.13.4 Hissen Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hissen Recent Developments/Updates
2.14 Jintan
2.14.1 Jintan Details
2.14.2 Jintan Major Business
2.14.3 Jintan Vaccines Product and Services
2.14.4 Jintan Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Jintan Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VACCINES BY MANUFACTURER
3.1 Global Vaccines Sales Quantity by Manufacturer (2020-2025)
3.2 Global Vaccines Revenue by Manufacturer (2020-2025)
3.3 Global Vaccines Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Vaccines Manufacturer Market Share in 2024
3.4.3 Top 6 Vaccines Manufacturer Market Share in 2024
3.5 Vaccines Market: Overall Company Footprint Analysis
3.5.1 Vaccines Market: Region Footprint
3.5.2 Vaccines Market: Company Product Type Footprint
3.5.3 Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Vaccines Market Size by Region
4.1.1 Global Vaccines Sales Quantity by Region (2020-2031)
4.1.2 Global Vaccines Consumption Value by Region (2020-2031)
4.1.3 Global Vaccines Average Price by Region (2020-2031)
4.2 North America Vaccines Consumption Value (2020-2031)
4.3 Europe Vaccines Consumption Value (2020-2031)
4.4 Asia-Pacific Vaccines Consumption Value (2020-2031)
4.5 South America Vaccines Consumption Value (2020-2031)
4.6 Middle East & Africa Vaccines Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Vaccines Sales Quantity by Type (2020-2031)
5.2 Global Vaccines Consumption Value by Type (2020-2031)
5.3 Global Vaccines Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Vaccines Sales Quantity by Application (2020-2031)
6.2 Global Vaccines Consumption Value by Application (2020-2031)
6.3 Global Vaccines Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Vaccines Sales Quantity by Type (2020-2031)
7.2 North America Vaccines Sales Quantity by Application (2020-2031)
7.3 North America Vaccines Market Size by Country
7.3.1 North America Vaccines Sales Quantity by Country (2020-2031)
7.3.2 North America Vaccines Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Vaccines Sales Quantity by Type (2020-2031)
8.2 Europe Vaccines Sales Quantity by Application (2020-2031)
8.3 Europe Vaccines Market Size by Country
8.3.1 Europe Vaccines Sales Quantity by Country (2020-2031)
8.3.2 Europe Vaccines Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Vaccines Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Vaccines Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Vaccines Market Size by Region
9.3.1 Asia-Pacific Vaccines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Vaccines Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Vaccines Sales Quantity by Type (2020-2031)
10.2 South America Vaccines Sales Quantity by Application (2020-2031)
10.3 South America Vaccines Market Size by Country
10.3.1 South America Vaccines Sales Quantity by Country (2020-2031)
10.3.2 South America Vaccines Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Vaccines Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Vaccines Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Vaccines Market Size by Country
11.3.1 Middle East & Africa Vaccines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Vaccines Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Vaccines Market Drivers
12.2 Vaccines Market Restraints
12.3 Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vaccines
13.3 Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vaccines Typical Distributors
14.3 Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Vaccines Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Vaccines Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Vaccines Product and Services
Table 6. GSK Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Vaccines Product and Services
Table 11. Sanofi Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Sanofi Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Vaccines Product and Services
Table 16. Merck Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Vaccines Product and Services
Table 21. Pfizer Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Pfizer Recent Developments/Updates
Table 23. Novartis(GSK) Basic Information, Manufacturing Base and Competitors
Table 24. Novartis(GSK) Major Business
Table 25. Novartis(GSK) Vaccines Product and Services
Table 26. Novartis(GSK) Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Novartis(GSK) Recent Developments/Updates
Table 28. CSL Basic Information, Manufacturing Base and Competitors
Table 29. CSL Major Business
Table 30. CSL Vaccines Product and Services
Table 31. CSL Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. CSL Recent Developments/Updates
Table 33. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 34. MedImmune LLC Major Business
Table 35. MedImmune LLC Vaccines Product and Services
Table 36. MedImmune LLC Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. MedImmune LLC Recent Developments/Updates
Table 38. J&J(Crucell) Basic Information, Manufacturing Base and Competitors
Table 39. J&J(Crucell) Major Business
Table 40. J&J(Crucell) Vaccines Product and Services
Table 41. J&J(Crucell) Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. J&J(Crucell) Recent Developments/Updates
Table 43. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 44. China National Biotec Major Business
Table 45. China National Biotec Vaccines Product and Services
Table 46. China National Biotec Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. China National Biotec Recent Developments/Updates
Table 48.Tiantan Basic Information, Manufacturing Base and Competitors
Table 49.Tiantan Major Business
Table 50.Tiantan Vaccines Product and Services
Table 51.Tiantan Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52.Tiantan Recent Developments/Updates
Table 53. Hualan Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Major Business
Table 55. Hualan Vaccines Product and Services
Table 56. Hualan Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hualan Recent Developments/Updates
Table 58. Kangtai Basic Information, Manufacturing Base and Competitors
Table 59. Kangtai Major Business
Table 60. Kangtai Vaccines Product and Services
Table 61. Kangtai Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Kangtai Recent Developments/Updates
Table 63. Hissen Basic Information, Manufacturing Base and Competitors
Table 64. Hissen Major Business
Table 65. Hissen Vaccines Product and Services
Table 66. Hissen Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Hissen Recent Developments/Updates
Table 68. Jintan Basic Information, Manufacturing Base and Competitors
Table 69. Jintan Major Business
Table 70. Jintan Vaccines Product and Services
Table 71. Jintan Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Jintan Recent Developments/Updates
Table 73. Global Vaccines Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 74. Global Vaccines Revenue by Manufacturer (2020-2025) & (USD Million)
Table 75. Global Vaccines Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 76. Market Position of Manufacturers in Vaccines, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 77. Head Office and Vaccines Production Site of Key Manufacturer
Table 78. Vaccines Market: Company ProductTypeFootprint
Table 79. Vaccines Market: Company Product ApplicationFootprint
Table 80. Vaccines New Market Entrants and Barriers to Market Entry
Table 81. Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Vaccines Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 83. Global Vaccines Sales Quantity by Region (2020-2025) & (K Units)
Table 84. Global Vaccines Sales Quantity by Region (2026-2031) & (K Units)
Table 85. Global Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 86. Global Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 87. Global Vaccines Average Price by Region (2020-2025) & (USD/Unit)
Table 88. Global Vaccines Average Price by Region (2026-2031) & (USD/Unit)
Table 89. Global Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 90. Global Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 91. Global Vaccines Consumption Value byType (2020-2025) & (USD Million)
Table 92. Global Vaccines Consumption Value byType (2026-2031) & (USD Million)
Table 93. Global Vaccines Average Price byType (2020-2025) & (USD/Unit)
Table 94. Global Vaccines Average Price byType (2026-2031) & (USD/Unit)
Table 95. Global Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 96. Global Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 97. Global Vaccines Consumption Value by Application (2020-2025) & (USD Million)
Table 98. Global Vaccines Consumption Value by Application (2026-2031) & (USD Million)
Table 99. Global Vaccines Average Price by Application (2020-2025) & (USD/Unit)
Table 100. Global Vaccines Average Price by Application (2026-2031) & (USD/Unit)
Table 101. North America Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 102. North America Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 103. North America Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 104. North America Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 105. North America Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 106. North America Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 107. North America Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 110. Europe Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 111. Europe Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 112. Europe Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 113. Europe Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 114. Europe Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 115. Europe Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 116. Europe Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Asia-Pacific Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 118. Asia-Pacific Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 119. Asia-Pacific Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 120. Asia-Pacific Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 121. Asia-Pacific Vaccines Sales Quantity by Region (2020-2025) & (K Units)
Table 122. Asia-Pacific Vaccines Sales Quantity by Region (2026-2031) & (K Units)
Table 123. Asia-Pacific Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 124. Asia-Pacific Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 125. South America Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 126. South America Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 127. South America Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 128. South America Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 129. South America Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 130. South America Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 131. South America Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 132. South America Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Middle East & Africa Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 134. Middle East & Africa Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 135. Middle East & Africa Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 136. Middle East & Africa Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 137. Middle East & Africa Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 138. Middle East & Africa Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 139. Middle East & Africa Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 140. Middle East & Africa Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 141. Vaccines Raw Material
Table 142. Key Manufacturers of Vaccines Raw Materials
Table 143. VaccinesTypical Distributors
Table 144. VaccinesTypical Customers
LIST OFFIGURES
Figure 1. Vaccines Picture
Figure 2. Global Vaccines Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Vaccines Revenue Market Share byType in 2024
Figure 4. Recombinant Vaccines Examples
Figure 5. Viral Vaccines Examples
Figure 6. Polysaccharide Vaccines Examples
Figure 7. Others Examples
Figure 8. Global Vaccines Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Vaccines Revenue Market Share by Application in 2024
Figure 10. Rabies vaccine Examples
Figure 11. Influenza vaccine Examples
Figure 12. HPV vaccine Examples
Figure 13. Hepatitis B Examples
Figure 14. Hepatitis A Examples
Figure 15. Leprosy vaccine Examples
Figure 16. Polio vaccine Examples
Figure 17. JE vaccine Examples
Figure 18. JE vaccine Examples
Figure 19. Global Vaccines Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 20. Global Vaccines Consumption Value andForecast (2020-2031) & (USD Million)
Figure 21. Global Vaccines Sales Quantity (2020-2031) & (K Units)
Figure 22. Global Vaccines Price (2020-2031) & (USD/Unit)
Figure 23. Global Vaccines Sales Quantity Market Share by Manufacturer in 2024
Figure 24. Global Vaccines Revenue Market Share by Manufacturer in 2024
Figure 25. Producer Shipments of Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 26.Top 3 Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 27.Top 6 Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 28. Global Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 29. Global Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 30. North America Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 31. Europe Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 32. Asia-Pacific Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 33. South America Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 34. Middle East & Africa Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 35. Global Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 36. Global Vaccines Consumption Value Market Share byType (2020-2031)
Figure 37. Global Vaccines Average Price byType (2020-2031) & (USD/Unit)
Figure 38. Global Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 39. Global Vaccines Revenue Market Share by Application (2020-2031)
Figure 40. Global Vaccines Average Price by Application (2020-2031) & (USD/Unit)
Figure 41. North America Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 42. North America Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 43. North America Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 44. North America Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 45. United States Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 46. Canada Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 47. Mexico Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 48. Europe Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 49. Europe Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 50. Europe Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 51. Europe Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 52. Germany Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 53.France Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 54. United Kingdom Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 55. Russia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 56. Italy Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 57. Asia-Pacific Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 58. Asia-Pacific Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 59. Asia-Pacific Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 60. Asia-Pacific Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 61. China Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 62. Japan Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 63. South Korea Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 64. India Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 65. Southeast Asia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 66. Australia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 67. South America Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 68. South America Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 69. South America Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 70. South America Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 71. Brazil Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 72. Argentina Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 73. Middle East & Africa Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 74. Middle East & Africa Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 75. Middle East & Africa Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 76. Middle East & Africa Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 77.Turkey Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 78. Egypt Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 79. Saudi Arabia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 80. South Africa Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 81. Vaccines Market Drivers
Figure 82. Vaccines Market Restraints
Figure 83. Vaccines MarketTrends
Figure 84. PortersFiveForces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Vaccines in 2024
Figure 86. Manufacturing Process Analysis of Vaccines
Figure 87. Vaccines Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Recombinant Vaccines
1.3.3 Viral Vaccines
1.3.4 Polysaccharide Vaccines
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Vaccines Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Rabies vaccine
1.4.3 Influenza vaccine
1.4.4 HPV vaccine
1.4.5 Hepatitis B
1.4.6 Hepatitis A
1.4.7 Leprosy vaccine
1.4.8 Polio vaccine
1.4.9 JE vaccine
1.4.10 Others
1.5 Global Vaccines Market Size & Forecast
1.5.1 Global Vaccines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Vaccines Sales Quantity (2020-2031)
1.5.3 Global Vaccines Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Vaccines Product and Services
2.1.4 GSK Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Vaccines Product and Services
2.2.4 Sanofi Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Sanofi Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Vaccines Product and Services
2.3.4 Merck Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Vaccines Product and Services
2.4.4 Pfizer Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Pfizer Recent Developments/Updates
2.5 Novartis(GSK)
2.5.1 Novartis(GSK) Details
2.5.2 Novartis(GSK) Major Business
2.5.3 Novartis(GSK) Vaccines Product and Services
2.5.4 Novartis(GSK) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Novartis(GSK) Recent Developments/Updates
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Vaccines Product and Services
2.6.4 CSL Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 CSL Recent Developments/Updates
2.7 MedImmune LLC
2.7.1 MedImmune LLC Details
2.7.2 MedImmune LLC Major Business
2.7.3 MedImmune LLC Vaccines Product and Services
2.7.4 MedImmune LLC Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 MedImmune LLC Recent Developments/Updates
2.8 J&J(Crucell)
2.8.1 J&J(Crucell) Details
2.8.2 J&J(Crucell) Major Business
2.8.3 J&J(Crucell) Vaccines Product and Services
2.8.4 J&J(Crucell) Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 J&J(Crucell) Recent Developments/Updates
2.9 China National Biotec
2.9.1 China National Biotec Details
2.9.2 China National Biotec Major Business
2.9.3 China National Biotec Vaccines Product and Services
2.9.4 China National Biotec Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 China National Biotec Recent Developments/Updates
2.10 Tiantan
2.10.1 Tiantan Details
2.10.2 Tiantan Major Business
2.10.3 Tiantan Vaccines Product and Services
2.10.4 Tiantan Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Tiantan Recent Developments/Updates
2.11 Hualan
2.11.1 Hualan Details
2.11.2 Hualan Major Business
2.11.3 Hualan Vaccines Product and Services
2.11.4 Hualan Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hualan Recent Developments/Updates
2.12 Kangtai
2.12.1 Kangtai Details
2.12.2 Kangtai Major Business
2.12.3 Kangtai Vaccines Product and Services
2.12.4 Kangtai Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Kangtai Recent Developments/Updates
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Vaccines Product and Services
2.13.4 Hissen Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Hissen Recent Developments/Updates
2.14 Jintan
2.14.1 Jintan Details
2.14.2 Jintan Major Business
2.14.3 Jintan Vaccines Product and Services
2.14.4 Jintan Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Jintan Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VACCINES BY MANUFACTURER
3.1 Global Vaccines Sales Quantity by Manufacturer (2020-2025)
3.2 Global Vaccines Revenue by Manufacturer (2020-2025)
3.3 Global Vaccines Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Vaccines Manufacturer Market Share in 2024
3.4.3 Top 6 Vaccines Manufacturer Market Share in 2024
3.5 Vaccines Market: Overall Company Footprint Analysis
3.5.1 Vaccines Market: Region Footprint
3.5.2 Vaccines Market: Company Product Type Footprint
3.5.3 Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Vaccines Market Size by Region
4.1.1 Global Vaccines Sales Quantity by Region (2020-2031)
4.1.2 Global Vaccines Consumption Value by Region (2020-2031)
4.1.3 Global Vaccines Average Price by Region (2020-2031)
4.2 North America Vaccines Consumption Value (2020-2031)
4.3 Europe Vaccines Consumption Value (2020-2031)
4.4 Asia-Pacific Vaccines Consumption Value (2020-2031)
4.5 South America Vaccines Consumption Value (2020-2031)
4.6 Middle East & Africa Vaccines Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Vaccines Sales Quantity by Type (2020-2031)
5.2 Global Vaccines Consumption Value by Type (2020-2031)
5.3 Global Vaccines Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Vaccines Sales Quantity by Application (2020-2031)
6.2 Global Vaccines Consumption Value by Application (2020-2031)
6.3 Global Vaccines Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Vaccines Sales Quantity by Type (2020-2031)
7.2 North America Vaccines Sales Quantity by Application (2020-2031)
7.3 North America Vaccines Market Size by Country
7.3.1 North America Vaccines Sales Quantity by Country (2020-2031)
7.3.2 North America Vaccines Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Vaccines Sales Quantity by Type (2020-2031)
8.2 Europe Vaccines Sales Quantity by Application (2020-2031)
8.3 Europe Vaccines Market Size by Country
8.3.1 Europe Vaccines Sales Quantity by Country (2020-2031)
8.3.2 Europe Vaccines Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Vaccines Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Vaccines Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Vaccines Market Size by Region
9.3.1 Asia-Pacific Vaccines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Vaccines Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Vaccines Sales Quantity by Type (2020-2031)
10.2 South America Vaccines Sales Quantity by Application (2020-2031)
10.3 South America Vaccines Market Size by Country
10.3.1 South America Vaccines Sales Quantity by Country (2020-2031)
10.3.2 South America Vaccines Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Vaccines Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Vaccines Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Vaccines Market Size by Country
11.3.1 Middle East & Africa Vaccines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Vaccines Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Vaccines Market Drivers
12.2 Vaccines Market Restraints
12.3 Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vaccines
13.3 Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vaccines Typical Distributors
14.3 Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Vaccines Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Vaccines Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Vaccines Product and Services
Table 6. GSK Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Vaccines Product and Services
Table 11. Sanofi Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Sanofi Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Vaccines Product and Services
Table 16. Merck Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Vaccines Product and Services
Table 21. Pfizer Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Pfizer Recent Developments/Updates
Table 23. Novartis(GSK) Basic Information, Manufacturing Base and Competitors
Table 24. Novartis(GSK) Major Business
Table 25. Novartis(GSK) Vaccines Product and Services
Table 26. Novartis(GSK) Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Novartis(GSK) Recent Developments/Updates
Table 28. CSL Basic Information, Manufacturing Base and Competitors
Table 29. CSL Major Business
Table 30. CSL Vaccines Product and Services
Table 31. CSL Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. CSL Recent Developments/Updates
Table 33. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 34. MedImmune LLC Major Business
Table 35. MedImmune LLC Vaccines Product and Services
Table 36. MedImmune LLC Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. MedImmune LLC Recent Developments/Updates
Table 38. J&J(Crucell) Basic Information, Manufacturing Base and Competitors
Table 39. J&J(Crucell) Major Business
Table 40. J&J(Crucell) Vaccines Product and Services
Table 41. J&J(Crucell) Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. J&J(Crucell) Recent Developments/Updates
Table 43. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 44. China National Biotec Major Business
Table 45. China National Biotec Vaccines Product and Services
Table 46. China National Biotec Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. China National Biotec Recent Developments/Updates
Table 48.Tiantan Basic Information, Manufacturing Base and Competitors
Table 49.Tiantan Major Business
Table 50.Tiantan Vaccines Product and Services
Table 51.Tiantan Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52.Tiantan Recent Developments/Updates
Table 53. Hualan Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Major Business
Table 55. Hualan Vaccines Product and Services
Table 56. Hualan Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hualan Recent Developments/Updates
Table 58. Kangtai Basic Information, Manufacturing Base and Competitors
Table 59. Kangtai Major Business
Table 60. Kangtai Vaccines Product and Services
Table 61. Kangtai Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Kangtai Recent Developments/Updates
Table 63. Hissen Basic Information, Manufacturing Base and Competitors
Table 64. Hissen Major Business
Table 65. Hissen Vaccines Product and Services
Table 66. Hissen Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Hissen Recent Developments/Updates
Table 68. Jintan Basic Information, Manufacturing Base and Competitors
Table 69. Jintan Major Business
Table 70. Jintan Vaccines Product and Services
Table 71. Jintan Vaccines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Jintan Recent Developments/Updates
Table 73. Global Vaccines Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 74. Global Vaccines Revenue by Manufacturer (2020-2025) & (USD Million)
Table 75. Global Vaccines Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 76. Market Position of Manufacturers in Vaccines, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 77. Head Office and Vaccines Production Site of Key Manufacturer
Table 78. Vaccines Market: Company ProductTypeFootprint
Table 79. Vaccines Market: Company Product ApplicationFootprint
Table 80. Vaccines New Market Entrants and Barriers to Market Entry
Table 81. Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Vaccines Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 83. Global Vaccines Sales Quantity by Region (2020-2025) & (K Units)
Table 84. Global Vaccines Sales Quantity by Region (2026-2031) & (K Units)
Table 85. Global Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 86. Global Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 87. Global Vaccines Average Price by Region (2020-2025) & (USD/Unit)
Table 88. Global Vaccines Average Price by Region (2026-2031) & (USD/Unit)
Table 89. Global Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 90. Global Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 91. Global Vaccines Consumption Value byType (2020-2025) & (USD Million)
Table 92. Global Vaccines Consumption Value byType (2026-2031) & (USD Million)
Table 93. Global Vaccines Average Price byType (2020-2025) & (USD/Unit)
Table 94. Global Vaccines Average Price byType (2026-2031) & (USD/Unit)
Table 95. Global Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 96. Global Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 97. Global Vaccines Consumption Value by Application (2020-2025) & (USD Million)
Table 98. Global Vaccines Consumption Value by Application (2026-2031) & (USD Million)
Table 99. Global Vaccines Average Price by Application (2020-2025) & (USD/Unit)
Table 100. Global Vaccines Average Price by Application (2026-2031) & (USD/Unit)
Table 101. North America Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 102. North America Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 103. North America Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 104. North America Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 105. North America Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 106. North America Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 107. North America Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 108. North America Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 109. Europe Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 110. Europe Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 111. Europe Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 112. Europe Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 113. Europe Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 114. Europe Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 115. Europe Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 116. Europe Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 117. Asia-Pacific Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 118. Asia-Pacific Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 119. Asia-Pacific Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 120. Asia-Pacific Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 121. Asia-Pacific Vaccines Sales Quantity by Region (2020-2025) & (K Units)
Table 122. Asia-Pacific Vaccines Sales Quantity by Region (2026-2031) & (K Units)
Table 123. Asia-Pacific Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 124. Asia-Pacific Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 125. South America Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 126. South America Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 127. South America Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 128. South America Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 129. South America Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 130. South America Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 131. South America Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 132. South America Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 133. Middle East & Africa Vaccines Sales Quantity byType (2020-2025) & (K Units)
Table 134. Middle East & Africa Vaccines Sales Quantity byType (2026-2031) & (K Units)
Table 135. Middle East & Africa Vaccines Sales Quantity by Application (2020-2025) & (K Units)
Table 136. Middle East & Africa Vaccines Sales Quantity by Application (2026-2031) & (K Units)
Table 137. Middle East & Africa Vaccines Sales Quantity by Country (2020-2025) & (K Units)
Table 138. Middle East & Africa Vaccines Sales Quantity by Country (2026-2031) & (K Units)
Table 139. Middle East & Africa Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 140. Middle East & Africa Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 141. Vaccines Raw Material
Table 142. Key Manufacturers of Vaccines Raw Materials
Table 143. VaccinesTypical Distributors
Table 144. VaccinesTypical Customers
LIST OFFIGURES
Figure 1. Vaccines Picture
Figure 2. Global Vaccines Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Vaccines Revenue Market Share byType in 2024
Figure 4. Recombinant Vaccines Examples
Figure 5. Viral Vaccines Examples
Figure 6. Polysaccharide Vaccines Examples
Figure 7. Others Examples
Figure 8. Global Vaccines Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Vaccines Revenue Market Share by Application in 2024
Figure 10. Rabies vaccine Examples
Figure 11. Influenza vaccine Examples
Figure 12. HPV vaccine Examples
Figure 13. Hepatitis B Examples
Figure 14. Hepatitis A Examples
Figure 15. Leprosy vaccine Examples
Figure 16. Polio vaccine Examples
Figure 17. JE vaccine Examples
Figure 18. JE vaccine Examples
Figure 19. Global Vaccines Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 20. Global Vaccines Consumption Value andForecast (2020-2031) & (USD Million)
Figure 21. Global Vaccines Sales Quantity (2020-2031) & (K Units)
Figure 22. Global Vaccines Price (2020-2031) & (USD/Unit)
Figure 23. Global Vaccines Sales Quantity Market Share by Manufacturer in 2024
Figure 24. Global Vaccines Revenue Market Share by Manufacturer in 2024
Figure 25. Producer Shipments of Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 26.Top 3 Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 27.Top 6 Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 28. Global Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 29. Global Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 30. North America Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 31. Europe Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 32. Asia-Pacific Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 33. South America Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 34. Middle East & Africa Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 35. Global Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 36. Global Vaccines Consumption Value Market Share byType (2020-2031)
Figure 37. Global Vaccines Average Price byType (2020-2031) & (USD/Unit)
Figure 38. Global Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 39. Global Vaccines Revenue Market Share by Application (2020-2031)
Figure 40. Global Vaccines Average Price by Application (2020-2031) & (USD/Unit)
Figure 41. North America Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 42. North America Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 43. North America Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 44. North America Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 45. United States Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 46. Canada Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 47. Mexico Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 48. Europe Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 49. Europe Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 50. Europe Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 51. Europe Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 52. Germany Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 53.France Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 54. United Kingdom Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 55. Russia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 56. Italy Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 57. Asia-Pacific Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 58. Asia-Pacific Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 59. Asia-Pacific Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 60. Asia-Pacific Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 61. China Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 62. Japan Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 63. South Korea Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 64. India Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 65. Southeast Asia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 66. Australia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 67. South America Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 68. South America Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 69. South America Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 70. South America Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 71. Brazil Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 72. Argentina Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 73. Middle East & Africa Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 74. Middle East & Africa Vaccines Sales Quantity Market Share by Application (2020-2031)
Figure 75. Middle East & Africa Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 76. Middle East & Africa Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 77.Turkey Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 78. Egypt Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 79. Saudi Arabia Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 80. South Africa Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 81. Vaccines Market Drivers
Figure 82. Vaccines Market Restraints
Figure 83. Vaccines MarketTrends
Figure 84. PortersFiveForces Analysis
Figure 85. Manufacturing Cost Structure Analysis of Vaccines in 2024
Figure 86. Manufacturing Process Analysis of Vaccines
Figure 87. Vaccines Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
More Publications
EMEA Vaccine Adjuvants Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
October 2017
124 pages
Global Pertussis Vaccine Consumption Market by Manufacturers, Regions, Type and Application, Forecast to 2021
US$ 3,480.00
August 2016
100 pages
Global Pertussis Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
94 pages
Global Vaccine Refrigerators Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 3,480.00
May 2017
163 pages
Asia-Pacific All Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022
US$ 4,480.00
July 2017
122 pages
